# Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine

> **NCT04942405** · PHASE3 · COMPLETED · sponsor: **Health Institutes of Turkey** · enrollment: 1290 (actual)

## Conditions studied

- Covid19

## Interventions

- **BIOLOGICAL:** TURCOVAC
- **BIOLOGICAL:** CoronaVac

## Key facts

- **NCT ID:** NCT04942405
- **Lead sponsor:** Health Institutes of Turkey
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-21
- **Primary completion:** 2023-03-08
- **Final completion:** 2024-02-01
- **Target enrollment:** 1290 (ACTUAL)
- **Last updated:** 2024-02-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04942405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04942405, "Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04942405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*